Design of Nanosuspensions and Freeze-Dried PLGA Nanoparticles as a Novel Approach for Ophthalmic Delivery of Pranoprofen

Akyol-Salman, 2007, Topical pranoprofen 0.1% is as effective anti-inflammatory and analgesic agent as diclofenac sodium 0.1% after strabismus surgery, J Ocul Pharmacol Ther, 23, 280, 10.1089/jop.2006.108 Sawa, 1999, Anti-inflamatory effect of diclofenac sodium eye drops on cataract surgery. Double masked study with pranoprofen eye drops, J Ocul Pharmcol Ther, 13, 193 McColgin, 2000, Control of intraocular inflammation associated with cataract surgery, Curr Opin Ophthalmol, 11, 3, 10.1097/00055735-200002000-00002 Liu, 2012, The effect of topical pranoprofen 0.1% on the clinical evaluation and conjunctival HLA-DR expression in dry eyes, Cornea, 31, 1235, 10.1097/ICO.0b013e31824988e5 Notivol, 1994, Treatment of chronic nonbacterial conjunctivitis with a cyclo-oxygenase inhibitor or a corticosteroid. Pranoprofen study group, Am J Ophthalmol, 117, 651, 10.1016/S0002-9394(14)70073-X Narashino, 1993 Kobe, 1999 Araújo, 2009, Nanomedicines for ocular NSAIDs: Safety on drug delivery, Nanomedicine, 5, 394, 10.1016/j.nano.2009.02.003 Nair, 2007, Biodegradable polymers as biomaterials, Prog Polym Sci, 32, 762, 10.1016/j.progpolymsci.2007.05.017 Laurent, 2008, Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications, Chem Rev, 108, 2064, 10.1021/cr068445e Abdelwahed, 2006, Freeze-drying of nanoparticles: Formulation, process and storage considerations, Adv Drug Deliv Rev, 58, 1688, 10.1016/j.addr.2006.09.017 Layre, 2006, Freeze-drying of composite core–shell nanoparticles, Drug Dev Ind Pharm, 32, 839, 10.1080/03639040600685134 Panyam, 2004, Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles, J Pharm Sci, 93, 1804, 10.1002/jps.20094 Fessi, 1989, Nanocapsule formation by interfacial polymer deposition following solvent displacement, Int J Pharm, 55, R1, 10.1016/0378-5173(89)90281-0 Fangueiro, 2012, Experimental factorial design applied to mucoadhesive lipid nanoparticles via multiple emulsion process, Colloids Surf B Biointerfaces, 100, 84, 10.1016/j.colsurfb.2012.04.014 Yegin, 2006, Lipid nanocapsule size analysis by hydrodynamic chromatography and photon correlation spectroscopy, Int J Pharm, 320, 165, 10.1016/j.ijpharm.2006.04.014 Teeranachaideekul, 2008, Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology, Int J Pharm, 354, 227, 10.1016/j.ijpharm.2007.11.062 Allémann, 1993, In vitro extended-release properties of drug-loaded poly(D,L-lactic acid) nanoparticles produced by a salting-out procedure, Pharm Res, 10, 1732, 10.1023/A:1018970030327 Celia, 2009, Turbiscan Lab® Expert analysis of the stability of ethosomes® and ultradeformable liposomes containing a bilayer fluidizing agent, Colloids Surf B Biointerfaces, 72, 155, 10.1016/j.colsurfb.2009.03.007 Franz, 1975, Percutaneous absorption. On the relevance of in vitro data, J Investig Dermatol, 64, 190, 10.1111/1523-1747.ep12533356 Costa, 2001, Modeling and comparison of dissolution profiles, Eur J Pharm Sci, 13, 123, 10.1016/S0928-0987(01)00095-1 Yamaoka, 1978, Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations, J Pharmacokinet Biopharm, 6, 165, 10.1007/BF01117450 Luepke, 1985, Hen's egg chorioallantoic membrane test for irritation potential, Food Chem Toxicol, 23, 287, 10.1016/0278-6915(85)90030-4 1990, Invittox-Protocol N.15 1996, Méthode Officiel d′evaluation du potentiel irritant par application sur la membrane chorioallantoidienne de l′oeuf de poule, Annexe IV, 1937 Zimmer, 1995, Microspheres and nanoparticles used in ocular delivery systems, Ocul Drug Deliv Rev, 16, 61, 10.1016/0169-409X(95)00017-2 Song, 2008, Dual agents loaded PLGA nanoparticles: Systematic study of particle size and drug entrapment efficiency, Eur J Pharm Biopharm, 69, 445, 10.1016/j.ejpb.2008.01.013 Win, 2005, Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs, Biomaterials, 26, 2713, 10.1016/j.biomaterials.2004.07.050 Anand, 2010, Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo, Biochem Pharmacol, 79, 330, 10.1016/j.bcp.2009.09.003 Feng, 2001, Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymers, J Control Release, 71, 53, 10.1016/S0168-3659(00)00364-3 Sahoo, 2002, Residual polyvinyl alcohol associated with poly (d,l-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake, J Control Release, 82, 105, 10.1016/S0168-3659(02)00127-X Araujo, 2009, Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres, Colloids Surf. B Biointerfaces, 72, 48, 10.1016/j.colsurfb.2009.03.028 Vega, 2006, Flurbiprofen loaded biodegradable nanoparticles for ophtalmic administration, J Pharm Sci, 95, 2393, 10.1002/jps.20685 Jiang, 2005, Ibuprofen-loaded nanoparticles prepared by a co-precipitation method and their release properties, Int J Pharm, 304, 220, 10.1016/j.ijpharm.2005.08.008 Zambaux, 1998, Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method, J Control Release, 50, 31, 10.1016/S0168-3659(97)00106-5 Murakami, 1999, Preparation of poly (d,l-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method, Int J Pharm, 187, 143, 10.1016/S0378-5173(99)00187-8 Zhao, 2010, Enhanced mechanical properties of graphene-based poly(vinyl alcohol) composites, Macromolecules, 43, 2357, 10.1021/ma902862u Vega, 2008, PLGA nanospheres for the ocular delivery of flurbiprofen: Drug release and interactions, J Pharm Sci, 97, 5306, 10.1002/jps.21383 Zeng, 2005, Influence of the drug compatibility with polymer solution on the release kinetics of electrospun fiber formulation, J Control Release, 105, 43, 10.1016/j.jconrel.2005.02.024 Konno, 2006, Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine, J Pharm Sci, 95, 2692, 10.1002/jps.20697 Jayasekara, 2004, Preparation, surface modification and characterization of solution cast starch PVA blended films, Polym Test, 23, 17, 10.1016/S0142-9418(03)00049-7 Dillen, 2004, Factorial design, physicochemical characterization and activity of ciprofloxacin-PLGA nanoparticles, Int J Pharm, 275, 171, 10.1016/j.ijpharm.2004.01.033 Toscani, 2012, Weak interactions in clobazam–lactose mixtures examined by differential scanning calorimetry: Comparison with the captopril–lactose system, Thermochim Acta, 543, 197, 10.1016/j.tca.2012.05.011 Kumar, 2000, Preparation of amorphous magnetite nanoparticles embedded in polyvinyl alcohol using ultrasound radiation, J Mater Chem, 10, 1125, 10.1039/b000440p Passerini, 2001, An investigation into the effects of residual water on the glass transition temperature of polylactide microspheres using modulated temperature DSC, J Control Release, 73, 111, 10.1016/S0168-3659(01)00245-0 Pistel, 2001, Brush-like branched biodegradable polyesters, part III Protein release from microspheres of poly(vinyl alcohol)-graft-poly (d,l-lactic-co-glycolic acid), J Control Release, 73, 7 Westedt, 2006, Paclitaxel releasing films consisting of poly (vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings, J Control Release, 111, 235, 10.1016/j.jconrel.2005.12.012 Faisant, 2002, PLGA-based microparticles: Elucidation of mechanisms and a new, simple mathematical model quantifying drug release, Eur J Pharm Sci, 15, 355, 10.1016/S0928-0987(02)00023-4 Niwa, 1993, Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with d,l-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior, J Control Release, 25, 89, 10.1016/0168-3659(93)90097-O Ford, 1987, Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropylmethylcellulose matrix tablets, Int J Pharm., 40, 223, 10.1016/0378-5173(87)90172-4 Tavaszi, 2007, The use of HET-CAM test in detecting the ocular irritation, Commun Agric Appl Biol Sci, 72, 137